Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical Study
S. Miyagawa, T. Kawamura, E. Ito, M. Takeda, H. Iseoka, J. Yokoyama, A. Harada, N. Mochizuki-Oda, Y. Imanishi-Ochi, J. Li, M. Sasai, F. Kitaoka, M. Nomura, N. Amano, T. Takahashi, , Y. Sawa
This pre-clinical study evaluates the safety and efficacy of clinical-grade human iPSC-derived cardiomyocyte patches in treating heart failure, showing improved cardiac function and no adverse effects.
bioRxiv · Apr 7, 2021 · PreprintCell Biology